BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
000936 Jiangsu Huaxicun
- 6.99
- -0.04-0.57%
Market Closed May 15 15:00 CST
6.19BMarket Cap46.29P/E (TTM)
7.17High6.96Low253.17KlotVolume7.00Open7.03Pre Close178.58MTurnover2.86%Turnover Ratio52.95P/E (Static)886.01MShares9.2652wk High1.18P/B6.19BFloat Cap5.0652wk Low7.73Limit Up885.89MShs Float22.43Historical High6.33Limit Down2.99%Amplitude0.65Historical Low0.04Dividend TTM7.05Avg Price119.30KlotAsk0.57%Div YieldTTM100Lot Size130.38KlotBid
Jiangsu Huaxicun Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -16.17%443.13M | -33.70%441.78M | -47.76%332.49M | -39.66%492.32M | -20.33%528.58M | 2.39%666.34M | 3.50%636.5M | 5.60%815.86M | -15.23%663.49M | 9.19%650.76M |
| Transactional financial assets | -33.80%233.85M | -23.44%237.25M | -11.22%402.02M | -11.96%361.78M | -9.03%353.23M | -24.09%309.9M | 13.74%452.81M | 0.03%410.91M | -6.73%388.31M | -45.93%408.22M |
| Notes receivable and accounts receivable | 27.46%247.42M | 53.92%247.75M | 7.41%209.75M | 0.03%216.01M | -7.32%194.12M | -9.12%160.96M | 31.23%195.27M | 25.99%215.96M | 65.07%209.46M | 64.51%177.11M |
| -Notes receivable | 110.78%104.54M | 133.46%119.57M | 4.96%72.34M | -33.48%52.8M | -29.34%49.59M | -9.49%51.22M | --68.92M | --79.38M | --70.19M | --56.59M |
| -Accounts receivable | -1.14%142.88M | 16.80%128.18M | 8.75%137.41M | 19.50%163.21M | 3.77%144.53M | -8.94%109.74M | -15.09%126.35M | -20.32%136.58M | 9.75%139.27M | 11.94%120.52M |
| Other receivables (including interest and dividends) | -98.05%1.32M | -8.61%1.3M | -81.49%6.24M | -81.51%6.23M | 19.15%67.56M | 47.18%1.42M | 57.17%33.73M | -39.14%33.71M | -21.02%56.7M | -13.17%967.07K |
| -Dividend receivable | ---- | ---- | ---- | ---- | --61.39M | ---- | 60.00%32.74M | -39.83%32.74M | ---- | ---- |
| -Other receivable | ---- | -8.61%1.3M | ---- | 541.69%6.23M | ---- | 47.18%1.42M | ---- | -0.86%971.41K | ---- | -13.17%967.07K |
| Advance payment | -77.63%20.99M | -28.97%25.19M | -35.93%68.8M | 28.65%55.49M | 79.63%93.83M | -6.60%35.47M | 60.38%107.38M | -39.17%43.13M | 49.64%52.23M | 215.47%37.97M |
| Inventories | 37.32%422.54M | 35.70%454.09M | 85.93%362.14M | 97.78%303.63M | 26.69%307.7M | 119.76%334.63M | 6.52%194.77M | 17.53%153.52M | 8.62%242.87M | -33.20%152.27M |
| Receivable financing | 99.60%289.17M | 41.57%200.88M | 11.45%181.88M | 9.77%170.59M | 0.20%144.87M | -6.41%141.9M | -21.26%163.19M | -22.87%155.41M | -30.35%144.58M | -36.52%151.61M |
| Other current assets | -42.12%17.06M | -29.42%22.29M | 246.60%25.53M | 525.83%24.75M | 100.85%29.47M | 367.04%31.59M | 62.34%7.37M | -45.54%3.96M | 27.55%14.67M | -58.34%6.76M |
| Total current assets | -2.55%1.68B | -3.07%1.63B | -11.29%1.59B | -11.00%1.63B | -2.99%1.72B | 6.09%1.68B | 8.88%1.79B | 0.66%1.83B | -5.49%1.77B | -18.88%1.59B |
| Non Current assets | ||||||||||
| Other non-current financial assets | 27.59%841.95M | 27.59%841.95M | 26.26%827.41M | 26.26%827.41M | 0.70%659.91M | 0.70%659.91M | -7.48%655.34M | -7.48%655.34M | -7.48%655.34M | -7.48%655.34M |
| Long-term equity investment | 0.27%3.53B | -2.51%3.48B | -1.27%3.55B | -1.11%3.54B | -2.88%3.52B | -1.10%3.57B | 1.12%3.59B | 0.99%3.58B | 3.67%3.62B | 1.97%3.61B |
| Fixed assets | ---- | 18.56%552.83M | ---- | 1.58%476.13M | ---- | -4.29%466.3M | ---- | 15.85%468.73M | ---- | 15.21%487.21M |
| Fixed assets liquidation | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Constru in process | ---- | -0.62%23.58M | ---- | 323.36%60.49M | ---- | 355.11%23.73M | ---- | -81.48%14.29M | ---- | -90.52%5.21M |
| Construction materials | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Intangible assets | -3.92%19.12M | -3.88%19.32M | -3.84%19.51M | -3.81%19.71M | -3.77%19.9M | -3.73%20.1M | -3.70%20.29M | -3.67%20.49M | -3.63%20.68M | -3.60%20.88M |
| Goodwill | 0.00%2.06M | 0.00%2.06M | 0.00%2.06M | 0.00%2.06M | 0.00%2.06M | 0.00%2.06M | 0.00%2.06M | 0.00%2.06M | 0.00%2.06M | 0.00%2.06M |
| Deferred tax assets | 43.94%33.62M | 56.19%36.13M | 4.15%25.13M | -2.01%23.72M | -4.45%23.36M | -2.43%23.13M | 128.41%24.13M | 123.59%24.21M | 119.76%24.45M | 126.60%23.71M |
| Other non current assets | -70.56%484.2K | -80.35%1.55M | 24.56%5.44M | -48.58%2.54M | -36.11%1.64M | 173.23%7.88M | 45.70%4.37M | -21.66%4.94M | -58.25%2.57M | -56.24%2.88M |
| Total non current assets | 5.33%5B | 3.87%4.96B | 4.63%5B | 3.82%4.96B | -1.31%4.75B | -0.71%4.77B | -0.30%4.78B | -0.11%4.77B | 2.01%4.81B | 0.84%4.81B |
| Total assets | 3.24%6.68B | 2.06%6.59B | 0.29%6.59B | -0.29%6.59B | -1.76%6.47B | 0.98%6.46B | 2.05%6.57B | 0.10%6.61B | -0.13%6.58B | -4.89%6.39B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 0.82%1.05B | -10.59%978.29M | -7.67%1.03B | -12.13%1.09B | -14.72%1.04B | 2.37%1.09B | -2.83%1.11B | 20.52%1.24B | 8.85%1.22B | -1.11%1.07B |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.09M | ---- | ---- |
| Notes payable and accounts payable | 31.46%86.98M | 103.56%157.54M | 53.41%95.84M | 16.31%83.17M | -19.12%66.16M | -3.59%77.4M | -34.86%62.48M | -39.55%71.51M | -27.89%81.8M | -29.68%80.28M |
| -Accounts payable | 31.46%86.98M | 103.56%157.54M | 53.41%95.84M | 16.31%83.17M | -19.12%66.16M | -3.59%77.4M | -34.86%62.48M | 4.70%71.51M | 28.95%81.8M | 25.13%80.28M |
| Contract liabilities | 33.08%150.3M | 51.00%87.52M | -9.58%108.28M | 70.96%109.31M | 35.21%112.94M | 14.19%57.96M | 78.80%119.76M | -26.44%63.94M | 15.01%83.53M | -34.51%50.76M |
| Advance receipts | -14.46%2.76M | -53.76%3.3M | 10.27%3.09M | -19.04%2.18M | -18.38%3.22M | -6.75%7.13M | -54.83%2.8M | -43.34%2.69M | 1.36%3.95M | 134.85%7.64M |
| Salaries payable | 10.11%16.17M | -0.43%35.04M | -4.42%25.92M | -15.49%18.2M | 5.62%14.69M | 0.94%35.19M | -15.49%27.12M | -8.27%21.53M | 38.95%13.91M | 4.83%34.86M |
| Taxs payable | 579.01%17.07M | 434.86%13.85M | 135.05%20.92M | -50.54%9.26M | -87.17%2.51M | -87.37%2.59M | -69.44%8.9M | -31.78%18.72M | -68.39%19.6M | -90.59%20.5M |
| Other payable (including interest and dividends) | -24.42%526.68K | -10.28%544.75K | -48.03%539.07K | -2.63%18.31M | -35.54%696.9K | -12.19%607.18K | 1.18%1.04M | -58.21%18.8M | 573.45%1.08M | 752.55%691.49K |
| -Dividend payable | ---- | ---- | ---- | 0.00%17.72M | ---- | ---- | ---- | -60.00%17.72M | ---- | ---- |
| -Other payable | ---- | -10.28%544.75K | ---- | -45.62%589.34K | ---- | -12.19%607.18K | ---- | 55.10%1.08M | ---- | 752.55%691.49K |
| Other current liabilities | 120.65%69.44M | 153.64%77.17M | 6.97%52.76M | -7.56%34.79M | -24.45%31.47M | -11.24%30.43M | 541.38%49.32M | 317.56%37.64M | 325.91%41.66M | 215.92%34.28M |
| Total current liabilities | 9.44%1.39B | 3.66%1.35B | -3.58%1.34B | -7.72%1.37B | -13.20%1.27B | 0.59%1.31B | -0.01%1.39B | 10.07%1.48B | 5.22%1.47B | -15.61%1.3B |
| Current liabilities | ||||||||||
| Long term loan | --19.52M | --19.52M | --20M | --20M | ---- | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | -37.32%21.85M | -6.24%29.27M | -43.82%22.21M | -36.08%21.97M | -7.46%34.85M | -25.78%31.21M | -3.41%39.54M | -23.66%34.37M | -15.18%37.67M | -23.82%42.06M |
| Long term deferred income | -11.43%3.63M | -11.11%3.75M | --3.87M | --3.99M | --4.1M | --4.22M | ---- | ---- | ---- | ---- |
| Total non current liabilities | 15.53%45.01M | 48.26%52.54M | 16.55%46.08M | 33.70%45.95M | 3.43%38.96M | -15.74%35.44M | -3.41%39.54M | -23.66%34.37M | -15.18%37.67M | -23.82%42.06M |
| Total liabilities | 9.62%1.44B | 4.84%1.41B | -3.02%1.38B | -6.78%1.41B | -12.78%1.31B | 0.07%1.34B | -0.11%1.43B | 8.97%1.51B | 4.59%1.5B | -15.89%1.34B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%886.01M | 0.00%886.01M | 0.00%886.01M | 0.00%886.01M | 0.00%886.01M | 0.00%886.01M | 0.00%886.01M | 0.00%886.01M | 0.00%886.01M | 0.00%886.01M |
| Capital reserve funds | -1.58%384.87M | -1.58%384.87M | 1.89%392.98M | 2.68%393.01M | 1.88%391.05M | 1.88%391.05M | -1.68%385.68M | -23.18%382.76M | -22.24%383.82M | -22.24%383.82M |
| Surplus reserve funds | 3.44%450.64M | 3.44%450.64M | 2.80%437.26M | 2.80%437.26M | 2.43%435.67M | 2.43%435.67M | 2.94%425.34M | 2.94%425.34M | 2.94%425.34M | 2.94%425.34M |
| Retained profit | 2.43%3.51B | 1.97%3.46B | 1.82%3.48B | 2.31%3.45B | 1.85%3.43B | 1.33%3.39B | 3.09%3.42B | 3.18%3.37B | 4.17%3.37B | 4.10%3.35B |
| Other composite income | -65.66%4.63M | -58.75%5.33M | -78.57%5.33M | -66.19%8.5M | -22.04%13.48M | -2.76%12.93M | 3,871.82%24.87M | 212.89%25.13M | 6,192.98%17.29M | 5,897.35%13.3M |
| Shareholders equity without minority interests | 1.61%5.24B | 1.33%5.18B | 1.21%5.2B | 1.64%5.17B | 1.50%5.16B | 1.22%5.12B | 2.66%5.14B | 0.35%5.09B | 1.09%5.08B | 0.95%5.05B |
| Total shareholder equity | 1.61%5.24B | 1.33%5.18B | 1.21%5.2B | 1.64%5.17B | 1.50%5.16B | 1.22%5.12B | 2.66%5.14B | -2.27%5.09B | -1.44%5.08B | -1.48%5.05B |
| Total liabilityies and equity | 3.24%6.68B | 2.06%6.59B | 0.29%6.59B | -0.29%6.59B | -1.76%6.47B | 0.98%6.46B | 2.05%6.57B | 0.10%6.61B | -0.13%6.58B | -4.89%6.39B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | ZTE Accounting firm (Special General Partnership) | -- | -- | -- | ZTE Accounting firm (Special General Partnership) | -- | -- | -- | ZTE Accounting firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.